Increased expression of pentraxin 3 in placental tissues from patients with unexplained recurrent pregnancy loss

1Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2013; 99(1): 63.23095139Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy lossFertil Steril20139916310.1016/j.fertnstert.2012.09.02323095139Search in Google Scholar

2Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010; 93(4): 1234-1243.10.1016/j.fertnstert.2009.01.16619338986JaslowCRCarneyJLKuttehWHDiagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy lossesFertil Steril20109341234124319338986Open DOISearch in Google Scholar

3Ford HB, Schust DJ. Recurrent pregnancy loss: Etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009; 2(2): 76-83.19609401FordHBSchustDJRecurrent pregnancy loss: Etiology, diagnosis, and therapyRev Obstet Gynecol2009227683Search in Google Scholar

4Jeve YB, Davies W. Evidence-based management of recurrent miscarriages. J Hum Reprod Sci. 2014; 7(3): 159-169.10.4103/0974-1208.14247525395740JeveYBDaviesWEvidence-based management of recurrent miscarriagesJ Hum Reprod Sci201473159169422979025395740Open DOISearch in Google Scholar

5Christiansen OB. Reproductive immunology. Mol Immunol. 2013; 55(1): 8-15.10.1016/j.molimm.2012.08.02523062611ChristiansenOBReproductive immunologyMol Immunol201355181523062611Open DOISearch in Google Scholar

6Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard AR, Govande V, et al. Inflammation in complicated pregnancy and its outcome. Am J Perinatal. 2016; 33(14): 1337-1356.10.1055/s-0036-1582397KalagiriRRCarderTChoudhurySVoraNBallardARGovandeVet alInflammation in complicated pregnancy and its outcomeAm J Perinatal201633141337135627159203Open DOISearch in Google Scholar

7Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: The role of the immune system at the implantation site. Ann NY Acad Sci. 2011; 1221(1): 80-87.10.1111/j.1749-6632.2010.05938.xMorGCardenasIAbrahamsVGullerSInflammation and pregnancy: The role of the immune system at the implantation siteAnn NY Acad Sci2011122118087307858621401634Open DOISearch in Google Scholar

8Doni A, Garlanda C, Mantovani A. Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Semin Immunol. 2016; 28(6): 570-577.10.1016/j.smim.2016.10.01227881292DoniAGarlandaCMantovaniAInnate immunity, hemostasis and matrix remodeling: PTX3 as a linkSemin Immunol2016286570577541483327881292Open DOISearch in Google Scholar

9Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010; 28: 157-183.1996856110.1146/annurev-immunol-030409-101305BottazziBDoniAGarlandaCMantovaniAAn integrated view of humoral innate immunity: pentraxins as a paradigmAnnu Rev Immunol20102815718319968561Search in Google Scholar

10Garlanda C, Maina V, Cotena A, Moalli F. The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility. J Reprod Immunol. 2009; 83(1-2): 128-133.10.1016/j.jri.2009.05.00619900712GarlandaCMainaVCotenaAMoalliFThe soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertilityJ Reprod Immunol2009831-212813319900712Open DOISearch in Google Scholar

11Casula M, Montecucco F, Bonaventura A, Liberale L, Vecchié A, Dallegri F, et al. Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases. Vascul Pharmacol. 2017; 99: 1-12.2905108810.1016/j.vph.2017.10.003CasulaMMontecuccoFBonaventuraALiberaleLVecchiéADallegriFet alUpdate on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseasesVascul Pharmacol20179911229051088Search in Google Scholar

12Larsson A, Palm M, Helmersson J, Axelsson O. Pentraxin 3 values during normal pregnancy. Inflammation. 2011; 34(5): 448-451.10.1007/s10753-010-9252-x20852923LarssonAPalmMHelmerssonJAxelssonOPentraxin 3 values during normal pregnancyInflammation201134544845120852923Open DOISearch in Google Scholar

13Lekva T, Michelsen AE, Bollerslev J, Norwitz ER, Aukrust P, Henriksen T, et al. Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: A 5-year follow-up study. Cardiovasc Diabetol. 2016; 15:23.10.1186/s12933-016-0345-126842615LekvaTMichelsenAEBollerslevJNorwitzERAukrustPHenriksenTet alLow circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: A 5-year follow-up studyCardiovasc Diabetol20161523473942626842615Open DOISearch in Google Scholar

14Rovere-Querini P, Antonacci S, Dell'Antonio G, Angeli A, Almirante G, Cin ED. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006; 108(1): 148-155.10.1097/01.AOG.0000224607.46622.bcRovere-QueriniPAntonacciSDell'AntonioGAngeliAAlmiranteGCinEDPlasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsiaObstet Gynecol2006108114815516816069Open DOISearch in Google Scholar

15Willeke F, Assad A, Findeisen P, Schromm E, Grobholz R, von Gerstenbergk B, et al. Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma. Eur J Cancer. 2006; 42(15): 2639-2646.1695948510.1016/j.ejca.2006.05.035WillekeFAssadAFindeisenPSchrommEGrobholzRvonGerstenbergk Bet alOverexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcomaEur J Cancer200642152639264616959485Search in Google Scholar

16Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, et al. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol. 2014; 165(3): 165-178.10.1159/000368778JaillonSBonavitaEGentileSRubinoMLafaceIGarlandaCet alThe long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseasesInt Arch Allergy Immunol2014165316517825531094Open DOISearch in Google Scholar

17Giacomini A, Ghedini GC, Presta M, Ronca, R. Long pentraxin 3: A novel multifaceted player in cancer. Biochim Biophys Acta. 2018; 1869(1): 53-63.GiacominiAGhediniGCPrestaMRoncaRLong pentraxin 3: A novel multifaceted player in cancerBiochim Biophys Acta201818691536310.1016/j.bbcan.2017.11.00429175552Search in Google Scholar

18Cozzi V, Garlanda C, Nebuloni M, Maina V, Martinelli A, Calabrese S, et al. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta. 2012; 33(12): 1039-1044.10.1016/j.placenta.2012.09.00923062219CozziVGarlandaCNebuloniMMainaVMartinelliACalabreseSet alPTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGRPlacenta201233121039104423062219Open DOISearch in Google Scholar

19Zhou P, Luo X, Qi HB,Zong WJ, Zhang H, Liu DD, et al. The expression of pentraxin 3 and tumor necrosis factor-α is increased in preeclamptic placentai tissue and maternal serum. Inflamm Res. 2012; 61(9): 10051012.ZhouPLuoXQiHBZongWJZhangHLiuDDet alThe expression of pentraxin 3 and tumor necrosis factor-α is increased in preeclamptic placentai tissue and maternal serumInflamm Res20126191005101210.1007/s00011-012-0507-x22714118Search in Google Scholar

20Akolekar R, Casagrandi D, Livanos P, Tetteh A, Nicolaides KH. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009; 29(10): 934-938.1956560910.1002/pd.2311AkolekarRCasagrandiDLivanosPTettehANicolaidesKHMaternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancyPrenat Diagn2009291093493819565609Search in Google Scholar

21Baschat AA, Kasdaglis TL, Aberdeen GW, Turan OM, Kopelman JL, Atlas R, et al. Serum pentraxin-3 levels at 11 to 14 weeks' gestation: Association with maternal and placentai characteristics. Am J Obstet Gynecol. 2009; 201(3): 298.el-298.e6.19631929BaschatAAKasdaglisTLAberdeenGWTuranOMKopelmanJLAtlasRet alSerum pentraxin-3 levels at 11 to 14 weeks' gestation: Association with maternal and placentai characteristicsAm J Obstet Gynecol20092013298el-298.e610.1016/j.ajog.2009.05.03919631929Search in Google Scholar

22Cetin I, Cozzi V, Papageorghiou AT, Maina V, Montanelli A, Garlanda C, et al. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction. Acta Obstet Gynecol Scand. 2009; 88(7): 846-849.1954420210.1080/00016340902971441CetinICozziVPapageorghiouATMainaVMontanelliAGarlandaCet alFirst trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restrictionActa Obstet Gynecol Scand200988784684919544202Search in Google Scholar

23Tranguch S, Chakrabarty A, Guo Y, Wang H, Dey SK. Maternal pentraxin 3 deficiency compromises implantation in mice. Biol Reprod. 2007; 77(3): 425-432.10.1095/biolreprod.107.06241417538075TranguchSChakrabartyAGuoYWangHDeySKMaternal pentraxin 3 deficiency compromises implantation in miceBiol Reprod200777342543217538075Open DOISearch in Google Scholar

24Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, et al. Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology. 2006; 147(12): 5662-5675.10.1210/en.2006-0916PopoviciRMBetzlerNKKrauseMSLuoMJauckusJGermeyerAet alGene expression profiling of human endometrial-trophoblast interaction in a coculture modelEndocrinology2006147125662567516946011Open DOISearch in Google Scholar

25Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, et al. Decidual stromal cell response to paracrine signals from the trophoblast: Amplification of immune and angiogenic modulators. Biol Reprod. 2007; 76(1): 102-117.10.1095/biolreprod.106.05479117021345HessAPHamiltonAETalbiSDosiouCNyegaardMNayakNet alDecidual stromal cell response to paracrine signals from the trophoblast: Amplification of immune and angiogenic modulatorsBiol Reprod200776110211717021345Open DOISearch in Google Scholar

26Cruciani L, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Mazaki-Tovi S, et al. Pentraxin 3 in maternal circulation: An association with preterm labor and preterm PROM, but not with intra-amniotic infection/innammation. J Matern Fetal Neonatal Med. 2010; 23(10): 1097-1105.10.3109/14767050903551509CrucianiLRomeroRVaisbuchEKusanovicJPChaiworapongsaTMazaki-ToviSet alPentraxin 3 in maternal circulation: An association with preterm labor and preterm PROM, but not with intra-amniotic infection/innammationJ Matern Fetal Neonatal Med2010231010971105347114320121391Open DOISearch in Google Scholar

27Assi F, Fruscio R, Bonardi C, Ghidini A, Allavena P, Mantovani A, et al. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. Br J Obstet Gynaecol. 2007; 114(2): 143-147.10.1111/j.1471-0528.2006.01225.xAssiFFruscioRBonardiCGhidiniAAllavenaPMantovaniAet alPentraxin 3 in plasma and vaginal fluid in women with preterm deliveryBr J Obstet Gynaecol2007114214314717305891Open DOISearch in Google Scholar

28Jo YS, Cheon JY, Ahn JW, Kim Y, Lee GSR. Pentraxin 3 and lipid profile status in pregnancy. J Obstet Gynaecol. 2017; 37(3): 727-730.2842185310.1080/01443615.2017.1291596JoYSCheonJYAhnJWKimYLeeGSRPentraxin 3 and lipid profile status in pregnancyJ Obstet Gynaecol201737372773028421853Search in Google Scholar

29Ibrahim MI, Harb HM, Ellaithy MI, Elkabarity RH, Abdelgwad MH. First trimester assessment of pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2012; 165(1): 37-41.2288949210.1016/j.ejogrb.2012.07.016IbrahimMIHarbHMEllaithyMIElkabarityRHAbdelgwadMHFirst trimester assessment of pentraxin-3 levels in women with primary unexplained recurrent pregnancy lossEur J Obstet Gynecol Reprod Biol20121651374122889492Search in Google Scholar

30Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, et al. An alternative role of Clq in cell migration and tissue remodeling: Contribution to trophoblast invasion and placentai development. J Immunol. 2010; 185(7): 4420-4429.10.4049/jimmunol.0903215AgostinisCBullaRTripodoCGismondiAStabileHBossiFet alAn alternative role of Clq in cell migration and tissue remodeling: Contribution to trophoblast invasion and placentai developmentJ Immunol201018574420442920810993Open DOISearch in Google Scholar

31Kouser L, Madhukaran SP, Shastri A, Saraon A, Ferluga J, Al-Mozaini M, et al. Emerging and novel functions of complement protein Clq. Front Immunol. 2015; 6: 317.KouserLMadhukaranSPShastriASaraonAFerlugaJAl-MozainiMet alEmerging and novel functions of complement protein ClqFront Immunol2015631710.3389/fimmu.2015.00317448422926175731Search in Google Scholar

32Singh J, Ahmed A, Girardi G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension. 2011; 58(4): 716-724.10.1161/HYPERTENSIONAHA.111.17591921859968SinghJAhmedAGirardiGRole of complement component C1q in the onset of preeclampsia in miceHypertension201158471672421859968Open DOISearch in Google Scholar